Janssen Search
Search results
Ricardo Attar, Ph.D.
RICARDO ATTAR, Ph.D. VICE PRESIDENT ONCOLOGY TRANSLATIONAL RESEARCH Ricardo Attar, Ph.D. is Vice President, Oncology Translational Research, for the Janssen Pharmaceutical Companies of Johnson & Johnson. In this position, he leads the Translational ...
About DIA
The Disease Interception Accelerator The Disease Interception Accelerator (DIA), part of Janssen Research & Development, LLC, is working to harness cutting-edge science to seek the most tractable interception opportunities to identify and address the ...
Janssen Recognizes World Psoriasis Day
Janssen Recognizes World Psoriasis Day The Janssen Pharmaceutical Companies of Johnson & Johnson join the International Federation of Psoriasis Associations in support of World Psoriasis Day on October 29, an annual event dedicated to raising ...
Outpacing AMR Infections Through Innovations
Outpacing AMR Infections Through Innovations As scientists in the field of infectious diseases, it is our life’s work to research and develop solutions to some of the world’s most challenging and dangerous health concerns. While we have made tremendous ...
Janssen Announces Update to Phase 3 MACiTEPH Study Evaluating Macitentan 75mg in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Sep 06, 2023 United States RARITAN, NJ, September 6, 2023- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced its decision to stop the Phase 3 MACiTEPH study evaluating macitentan 75 mg in patients with Chronic Thromboembolic ...
Alexander Grunewald
Alexander Grunewald enables Janssen Healthcare Innovation’s (JHI) growth by identifying, valuing, and championing new business opportunities. Alexander builds strong external relationships with the healthcare innovation and investment communities in areas ...
Technology-Enabled Genomics
The rapid evolution of high-throughput sequencing technologies empowers us to collect high dimensional genomics data on huge numbers of patients, enabling the discovery of novel biomarkers, mechanisms of action and drug targets. Technology-Enabled ...
Recognizing World IBD Day 2017
Recognizing World IBD Day 2017 Today, May 19 th, and every day, our focus at Janssen Immunology remains on advancing the science and understanding of Inflammatory Bowel Disease (IBD) with patients at the forefront. As a gastroenterologist who practiced ...
Infectious Diseases & Vaccines
Infectious Diseases & Vaccines Infectious Diseases & Vaccines The structure of HIV Creating Treatments for Infectious Diseases Discovery & Development Global Reach Respiratory Infections Chronic Infections Bacterial Infections Other Focus ...
World Mental Health Day 2018: Addressing the Mental Health Needs of Torture Survivors
World Mental Health Day 2018: Addressing the Mental Health Needs of Torture Survivors It’s a hard-to-fathom fact that torture is still used throughout the world to inflict physical or psychological harm to punish, intimidate or gather information. ...